Anagrelide April 12, 2017 Anagrelide Trade Name Agrylin Orphan Indication Essential thrombocythemia USA Market Approval USA USA Designation Date 1988-01-27 00:00:00 Sponsor Roberts Pharmaceutical Corp.;Meridian Center III, 6 Industrial Way West;Eatontown, New Jersey, 07724
